Tag: SARS CoV2
Know how Trivitron Healthcare played a role in detecting Omicron variants,...
Trivitron’s COVIDSure, COVIDSure PRO and COVIDsure Direct RT-PCR Kits detect the conserved region of SARS-CoV-2 and ORF1ab, Envelope E-gene, and Nucleocapsid N-gene
IIT Roorkee researchers discover three antiviral molecules for treating SARS-COV2 virus
These studies have resulted in identifying antivirals that multi-target coronavirus proteins that will quickly direct the development of new antiviral therapy against SARS-CoV-2 and its emerging variants
Cipla Launches ‘RT Direct’ Multiplex real time PCR kit for Covid-19
RNA extraction free kit to deliver results in just 45 minutes
Rural innovator comes up with technology to kill SARS-CoV
Launching India’s first break-through innovative medical device technology, Instashield - an CCMB approved virus attenuation, which disables all kinds of virus including SARS-CoV
CSIR-CDRI scientists develop indigenous RT-PCR kit ‘Om’ for Omicron variant
Under the Government initiative to make India self-reliant in RT-PCR diagnostics, CDRI developed an indigenous RT-PCR diagnostic kit
Roche announces no anticipated impact of Omicron variant on its tests
As new variant strains emerge, we are swiftly taking adequate steps to ensure that our tests perform as expected," mentioned its statement issued on January 6, 2022
New study reveals high prevalence of post COVID-19 fatigue in patients...
Study conducted jointly by Fortis C-DOC, AIIMS, C-NET, N-DOC and Diabetes Foundation..........................
Phase-3 trial results show COVAXIN is 77.8% effective against symptomatic COVID-19
Efficacy analysis demonstrates COVAXIN to be 93.4% effective against severe symptomatic COVID-19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant..................................
Biophore applies for DCGI emergency use approval of Aviptadil for COVID-19
Aviptadil has shown significant results in clinical trials against COVID-19. Biophore has developed both the API and the formulation in-house...........................
Meril gets ICMR nod for indigenous Covid-19 self-test, CoviFind
A simple, less invasive nasal swab-based home test offering quick results in 15 minutes is priced at Rs. 250 per test and will be available in pharmacies across India............................